Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dezhong Guan

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Bioorganic & Medicinal Chemistry|May 12, 2026
Recent progress in small-molecule targeted therapies for melanoma treatmentXinrui Yuan, Hongyan Xu, Yifeng Pei, et al.
Bioorganic & Medicinal Chemistry Letters|October 10, 2021
Design, synthesis and biological evaluation of macrocyclic derivatives as TRK inhibitorsPei Li, Shi Cai, Tong Zhao, et al.
Molecular Diversity|March 18, 2024
Design, synthesis and biological evaluation of MNK-PROTACsXue Sun, Qingyun Wu, Hong Bu, et al.
Chemmedchem|May 18, 2026
Design, Synthesis, and Biological Evaluation of Small-Molecule PD-1/PD-L1 Inhibitors Bearing a Rigid Benz[d]oxazole SkeletonBo Wei, Xueling Ding, Peiyu Zhu, et al.
Chempluschem|June 25, 2026
Design, Synthesis, and Performance Characterization of BODIPY-Based NIR Probes for Aβ<sub>42</sub> Aggregate DetectionJiaoru Chen, Xueling Ding, Dezhong Guan, et al.
European Journal of Medicinal Chemistry|April 12, 2026
Dual BRD4/AKT inhibition overcomes c-MYC-driven resistance in metastatic castration-resistant prostate cancerFuao Zhang, Dezhong Guan, Wenjing Zhang, et al.
Journal of Medicinal Chemistry|April 2, 2024
Development of an Imidazopyridazine-Based MNK1/2 Inhibitor for the Treatment of LymphomaXinrui Yuan, Dezhong Guan, Chao Chen, et al.
Chemmedchem|March 1, 2024
Design, Synthesis, and Biological Evaluation of Eukaryotic Initiation Factor 2B (eIF2B) ActivatorsYifeng Pei, Sentao Liu, Lixun Wang, et al.
Analytical Chemistry|February 5, 2026
Rational Design of a Dual-Locked Fluorescent Probe for Precise Imaging of Tumor via β-Galactosidase/Viscosity ActivationXiaoyi Zhang, Jiaoru Chen, Bo Wei, et al.
European Journal of Medicinal Chemistry|February 15, 2024
Ecto-nucleotide pyrophosphatase/phosphodiesterase 1 inhibitors: Research progress and prospectsDezhong Guan, Lincheng Fang, Mingshun Feng, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Bioorganic & Medicinal Chemistry|May 12, 2026
Recent progress in small-molecule targeted therapies for melanoma treatmentXinrui Yuan, Hongyan Xu, Yifeng Pei, et al.
Bioorganic & Medicinal Chemistry Letters|October 10, 2021
Design, synthesis and biological evaluation of macrocyclic derivatives as TRK inhibitorsPei Li, Shi Cai, Tong Zhao, et al.
Molecular Diversity|March 18, 2024
Design, synthesis and biological evaluation of MNK-PROTACsXue Sun, Qingyun Wu, Hong Bu, et al.
Chemmedchem|May 18, 2026
Design, Synthesis, and Biological Evaluation of Small-Molecule PD-1/PD-L1 Inhibitors Bearing a Rigid Benz[d]oxazole SkeletonBo Wei, Xueling Ding, Peiyu Zhu, et al.
Chempluschem|June 25, 2026
Design, Synthesis, and Performance Characterization of BODIPY-Based NIR Probes for Aβ<sub>42</sub> Aggregate DetectionJiaoru Chen, Xueling Ding, Dezhong Guan, et al.
European Journal of Medicinal Chemistry|April 12, 2026
Dual BRD4/AKT inhibition overcomes c-MYC-driven resistance in metastatic castration-resistant prostate cancerFuao Zhang, Dezhong Guan, Wenjing Zhang, et al.
Journal of Medicinal Chemistry|April 2, 2024
Development of an Imidazopyridazine-Based MNK1/2 Inhibitor for the Treatment of LymphomaXinrui Yuan, Dezhong Guan, Chao Chen, et al.
Chemmedchem|March 1, 2024
Design, Synthesis, and Biological Evaluation of Eukaryotic Initiation Factor 2B (eIF2B) ActivatorsYifeng Pei, Sentao Liu, Lixun Wang, et al.
Analytical Chemistry|February 5, 2026
Rational Design of a Dual-Locked Fluorescent Probe for Precise Imaging of Tumor via β-Galactosidase/Viscosity ActivationXiaoyi Zhang, Jiaoru Chen, Bo Wei, et al.
European Journal of Medicinal Chemistry|February 15, 2024
Ecto-nucleotide pyrophosphatase/phosphodiesterase 1 inhibitors: Research progress and prospectsDezhong Guan, Lincheng Fang, Mingshun Feng, et al.
Pageof 2